Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
99.64
-1.36 (-1.35%)
At close: Jul 31, 2026, 4:00 PM EDT
98.00
-1.64 (-1.65%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Lantheus Holdings Revenue
Lantheus Holdings had revenue of $377.33M in the quarter ending March 31, 2026, with 1.23% growth. This brings the company's revenue in the last twelve months to $1.55B, up 0.62% year-over-year. In the year 2025, Lantheus Holdings had annual revenue of $1.54B with 0.50% growth.
Revenue (ttm)
$1.55B
Revenue Growth
+0.62%
P/S Ratio
4.20
Revenue / Employee
$1,296,042
Employees
1,193
Market Cap
6.49B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.54B | 7.70M | 0.50% |
| Dec 31, 2024 | 1.53B | 237.48M | 18.32% |
| Dec 31, 2023 | 1.30B | 361.37M | 38.65% |
| Dec 31, 2022 | 935.06M | 509.85M | 119.91% |
| Dec 31, 2021 | 425.21M | 85.80M | 25.28% |
| Dec 31, 2020 | 339.41M | -7.93M | -2.28% |
| Dec 31, 2019 | 347.34M | 3.96M | 1.15% |
| Dec 31, 2018 | 343.37M | 12.00M | 3.62% |
| Dec 31, 2017 | 331.38M | 29.53M | 9.78% |
| Dec 31, 2016 | 301.85M | 8.39M | 2.86% |
| Dec 31, 2015 | 293.46M | -8.14M | -2.70% |
| Dec 31, 2014 | 301.60M | 17.93M | 6.32% |
| Dec 31, 2013 | 283.67M | -4.43M | -1.54% |
| Dec 31, 2012 | 288.11M | -68.19M | -19.14% |
| Dec 31, 2011 | 356.29M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Elanco Animal Health | 4.89B |
| Dr. Reddy's Laboratories | 3.50B |
| Amneal Pharmaceuticals | 3.05B |
| Hims & Hers Health | 2.37B |
| Alkermes | 1.67B |
| Indivior Pharmaceuticals | 1.29B |
| Prestige Consumer Healthcare | 1.09B |
| Kiniksa Pharmaceuticals International, | 840.85M |
LNTH News
- 3 days ago - Lantheus price target raised to $129 from $97 at B. Riley - TheFly
- 3 days ago - Lantheus price target lowered to $115 from $120 at Mizuho - TheFly
- 3 days ago - Lantheus downgraded to Hold from Buy at Brookline - TheFly
- 4 days ago - Curium in talks to acquire Lantheus in roughly $7B deal, Bloomberg says - TheFly
- 9 days ago - Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time - GlobeNewsWire
- 16 days ago - Lantheus price target raised to $125 from $115 at Truist - TheFly
- 16 days ago - RadioMedix Appoints Brian A. Markison to Board of Directors - GlobeNewsWire
- 17 days ago - Lantheus price target raised to $120 from $115 at Mizuho - TheFly